Bachem Holding
Bachem Holding AG is a Swiss biochemical and contract development and manufacturing organization (CDMO) specializing in peptides and oligonucleotides. The company provides end-to-end services supporting the global pharmaceutical and biotechnology industries from early-stage research to commercial supply. Key product lines include active pharmaceutical ingredients (APIs), complex peptide molecules, and specialized biochemical reagents for medical therapies. Primary revenue is derived from contract manufacturing agreements, process development fees, and commercial-scale API deliveries to global biopharmaceutical clients. Bachem Holding holds a market-leading global position in chemical peptide synthesis and CDMO services. The company is headquartered in Bubendorf, Switzerland, and its shares trade on the SIX Swiss Exchange.
8 of the funds FundTelligence covers report a position in Bachem Holding.
- Legal name
- Bachem Holding AG
- Sector
- Health Care
- Country
- Switzerland
- Funds holding it
- 8
Funds holding Bachem Holding
- Schroder ISF European Smaller Companies — Schroders · 2.92 % (full portfolio disclosed, June 2026)
- BlackRock iShares Healthcare Innovation UCITS ETF — BlackRock · 0.29 % (full portfolio disclosed, October 2026)
- Handelsbanken Infrastruktur och Beredskap — Handelsbanken · 0.15 % (full portfolio disclosed, October 2026)
- Handelsbanken Global SMB Index Criteria — Handelsbanken · 0.04 % (full portfolio disclosed, October 2026)
- DNB Global Enhanced Small Cap — DNB · 0.04 % (full portfolio disclosed, September 2026)
- KLP AksjeGlobal Small Cap Indeks — KLP · 0.03 % (partially disclosed portfolio, June 2026)
- DNB Global Index — DNB · 0.0 % (full portfolio disclosed, September 2026)
- DNB Europe Index — DNB · 0.0 % (full portfolio disclosed, September 2026)